Cargando…
Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
OBJECTIVE—The aim of this study was to find an effective treatment for the genetic form of diabetes that is present in some Huntington's disease patients and in Huntington's disease mouse models. Huntington's disease is a neurodegenerative disorder caused by a polyglutamine expansion...
Autores principales: | Martin, Bronwen, Golden, Erin, Carlson, Olga D., Pistell, Paul, Zhou, Jie, Kim, Wook, Frank, Brittany P., Thomas, Sam, Chadwick, Wayne A., Greig, Nigel H., Bates, Gillian P., Sathasivam, Kirupa, Bernier, Michel, Maudsley, Stuart, Mattson, Mark P., Egan, Josephine M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628604/ https://www.ncbi.nlm.nih.gov/pubmed/18984744 http://dx.doi.org/10.2337/db08-0799 |
Ejemplares similares
-
Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Mason, Michael A., et al.
Publicado: (2020) -
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
por: Sathasivam, Kirupa, et al.
Publicado: (2010) -
Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging
por: Golden, Erin, et al.
Publicado: (2010) -
Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
por: Wang, Rui, et al.
Publicado: (2014) -
Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease
por: Zhou, Ya, et al.
Publicado: (2021)